Geode Capital Management, LLC Marker Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.24 - $4.58 $374 - $7,153	-1,562 Reduced 0.27%	577,537 $152,000
Q1 2022 May 13, 2022	BUY	$0.37 - $1.0 $8,656 - $23,397	23,397 Added 4.21%	579,099 $254,000
Q4 2021 Feb 11, 2022	SELL	$0.95 - $1.72 $40 - $73	-43 Reduced 0.01%	555,702 $528,000
Q3 2021 Nov 12, 2021	BUY	$1.68 - $2.88 $14,945 - $25,620	8,896 Added 1.63%	555,745 $939,000
Q2 2021 Aug 13, 2021	BUY	$1.88 - $3.56 $114,347 - $216,529	60,823 Added 12.51%	546,849 $1.53 Million
Q1 2021 May 12, 2021	SELL	$1.47 - $3.29 $58,569 - $131,083	-39,843 Reduced 7.58%	486,026 $1.09 Million
Q4 2020 Feb 12, 2021	BUY	$1.36 - $1.75 $24,746 - $31,843	18,196 Added 3.58%	525,869 $762,000
Q3 2020 Nov 13, 2020	BUY	$1.5 - $2.2 $51,493 - $75,523	34,329 Added 7.25%	507,673 $761,000
Q2 2020 Aug 13, 2020	BUY	$1.69 - $2.79 $66,286 - $109,432	39,223 Added 9.04%	473,344 $979,000
Q1 2020 May 14, 2020	BUY	$1.59 - $3.35 $1,186 - $2,499	746 Added 0.17%	434,121 $824,000
Q4 2019 Feb 13, 2020	BUY	$2.68 - $4.85 $79,156 - $143,249	29,536 Added 7.31%	433,375 $1.25 Million
Q3 2019 Nov 12, 2019	BUY	$4.1 - $9.0 $112,249 - $246,402	27,378 Added 7.27%	403,839 $2.06 Million
Q2 2019 Aug 14, 2019	BUY	$5.15 - $7.92 $711,673 - $1.09 Million	138,189 Added 58.0%	376,461 $2.98 Million
Q1 2019 May 14, 2019	BUY	$5.1 - $6.71 $4,131 - $5,435	810 Added 0.34%	238,272 $1.57 Million
Q4 2018 Feb 13, 2019	BUY	$4.2 - $9.74 $997,340 - $2.31 Million	237,462 New	237,462 $1.32 Million

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $134M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.